Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
40
DBVT Quote, Financials, Valuation and Earnings
Last price:
$4.84
Seasonality move
:
8.01%
Day range:
$4.66 - $4.80
52-week range:
$2.20 - $8.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.78x
Volume:
5.9K
Avg. volume:
24.9K
1-year change:
-40.76%
Market cap:
$96M
Revenue:
--
EPS (TTM):
-$5.25
DBV Technologies SA Number of Institutional Trades
DBV Technologies SA Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$17M
(Last 6 Months)
Current Institutional Ownership Percentage
18.28%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$107.3M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DBV Technologies SA Institutional Ownership
-
What Percentage Of DBVT Is Owned by Institutions?
18.28% of DBVT is owned by institutions.
-
How Many Institutions Own DBVT Shares?
DBV Technologies SA stock is owned by 38 institutional shareholders at this time.
-
Have Institutions Been Buying DBVT Stock?
Yes, institutions have bought 1.9M shares of DBVT in the last quarter.
-
Have Institutions Been Selling DBVT Stock?
Yes, institutions have sold 14M shares of DBVT over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
